• Published on 2023-02-05
    • Report Code: 1354
    • 170 - 350 pages

Respiratory Disorders Treatment Market

Respiratory Disorders Treatment Market: By Disease (Asthma, Chronic Obstructive Pulmonary Disease [COPD], Lung Cancer, Respiratory Tract Infection, Allergic Rhinitis, Cystic Fibrosis [CF], Others), By Route of Administration (Oral, Nasal, Injectable), By Drug Class (Bronchodilators, Corticosteroids, Combination Drugs, Antibiotics, Target Therapy, Immunotherapy, CFTR, Others), And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032

Table Of Content

CONTENTS

1 Executive Summary 
    1.1. Regional Market Share 
    1.2. Business Trends 
    1.3. Respiratory Disorders Treatment Market: COVID-19 Outbreak 
    1.4. Regional Trends 
    1.5. Segmentation Snapshot 

2 Research Methodology 
    2.1. Research Objective 
    2.2. Research Approach 
    2.3. Data Sourcing and Methodology 
    2.4. Primary Research 
    2.5. Secondary Research 
           2.5.1.  Paid Sources
           2.5.2.  Public Sources
    2.6. Market Size Estimation and Data Triangulation 

3 Market Characteristics 
    3.1. Market Definition 
    3.2.  Respiratory Disorders Treatment Market: COVID-19 Impact 
    3.3. Key Segmentations 
    3.4. Key Developments 
    3.5. Allied Industry Data 

4 Respiratory Disorders Treatment Market – Industry Insights 
    4.1. Industry Segmentation 
    4.2. COVID-19 overview on world economy 
    4.3. Industry ecosystem Channel analysis 
    4.4. Innovation & Sustainability 

5 Macroeconomic Indicators 

6 Recent Developments 

7 Market Dynamics 
    7.1. Introduction 
    7.2. Growth Drivers 
    7.3. Market Opportunities 
    7.4. Market Restraints 
    7.5. Market Trends 

8 Risk Analysis 

9 Market Analysis 
    9.1. Porters Five Forces 
    9.2. PEST Analysis 
           9.2.1. Political
           9.2.2. Economic
           9.2.3. Social
           9.2.4. Technological

10 Respiratory Disorders Treatment Market  
     10.1. Overview 
     10.2. Historical Analysis (2016-2020) 
             10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

11  Respiratory Disorders Treatment Market Size & Forecast 2022A-2032F 
     11.1. Overview 
     11.2. Key Findings 
     11.3. Market Segmentation 
             11.3.1. By Disease
                        11.3.1.1. Asthma
                                     11.3.1.1.1 By Value (USD Million) 2022-2032F
                                     11.3.1.1.2 Market Share (%) 2022-2032F
                                     11.3.1.1.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.1.2. Chronic Obstructive Pulmonary Disease (COPD)
                                     11.3.1.2.1 By Value (USD Million) 2022-2032F
                                     11.3.1.2.2 Market Share (%) 2022-2032F
                                     11.3.1.2.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.1.3. Lung Cancer
                                     11.3.1.3.1 By Value (USD Million) 2022-2032F
                                     11.3.1.3.2 Market Share (%) 2022-2032F
                                     11.3.1.3.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.1.4. Respiratory Tract Infection
                                     11.3.1.4.1 By Value (USD Million) 2022-2032F
                                     11.3.1.4.2 Market Share (%) 2022-2032F
                                     11.3.1.4.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.1.5. Allergic Rhinitis
                                     11.3.1.5.1 By Value (USD Million) 2022-2032F
                                     11.3.1.5.2 Market Share (%) 2022-2032F
                                     11.3.1.5.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.1.6. Cystic Fibrosis (CF)
                                     11.3.1.6.1 By Value (USD Million) 2022-2032F
                                     11.3.1.6.2 Market Share (%) 2022-2032F
                                     11.3.1.6.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.1.7. Others
                                     11.3.1.7.1 By Value (USD Million) 2022-2032F
                                     11.3.1.7.2 Market Share (%) 2022-2032F
                                     11.3.1.7.3 Y-o-Y Growth (%) 2022-2032F
             11.3.2. By Route of Administration
                        11.3.2.1. Oral
                                     11.3.2.1.1 By Value (USD Million) 2022-2032F
                                     11.3.2.1.2 Market Share (%) 2022-2032F
                                     11.3.2.1.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.2.2. Nasal
                                     11.3.2.2.1 By Value (USD Million) 2022-2032F
                                     11.3.2.2.2 Market Share (%) 2022-2032F
                                     11.3.2.2.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.2.3. Injectable
                                     11.3.2.3.1 By Value (USD Million) 2022-2032F
                                     11.3.2.3.2 Market Share (%) 2022-2032F

             11.3.3. By Drug Class
                        11.3.3.1. Bronchodilators
                                     11.3.3.1.1 By Value (USD Million) 2022-2032F
                                     11.3.3.1.2 Market Share (%) 2022-2032F
                                     11.3.3.1.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.3.2. Corticosteroids
                                     11.3.3.2.1 By Value (USD Million) 2022-2032F
                                     11.3.3.2.2 Market Share (%) 2022-2032F
                                     11.3.3.2.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.3.3. Combination Drugs
                                     11.3.3.3.1 By Value (USD Million) 2022-2032F
                                     11.3.3.3.2 Market Share (%) 2022-2032F
                                     11.3.3.3.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.3.4. Antibiotics
                                     11.3.3.4.1 By Value (USD Million) 2022-2032F
                                     11.3.3.4.2 Market Share (%) 2022-2032F
                                     11.3.3.4.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.3.5. Target Therapy
                                     11.3.3.5.1 By Value (USD Million) 2022-2032F
                                     11.3.3.5.2 Market Share (%) 2022-2032F
                                     11.3.3.5.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.3.6. Immunotherapy
                                     11.3.3.6.1 By Value (USD Million) 2022-2032F
                                     11.3.3.6.2 Market Share (%) 2022-2032F
                                     11.3.3.6.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.3.7. CFTR
                                     11.3.3.7.1 By Value (USD Million) 2022-2032F
                                     11.3.3.7.2 Market Share (%) 2022-2032F
                                     11.3.3.7.3 Y-o-Y Growth (%) 2022-2032F
                        11.3.3.8. Others
                                     11.3.3.8.1 By Value (USD Million) 2022-2032F
                                     11.3.3.8.2 Market Share (%) 2022-2032F
                                     11.3.3.8.3 Y-o-Y Growth (%) 2022-2032F

12 North America Respiratory Disorders Treatment Market Size & Forecast 2022A-2032F 
     12.1. Overview 
     12.2. Key Findings 
     12.3. Market Segmentation 
             12.3.1. By Disease
             12.3.2. By Route of Administration
             12.3.3. By Drug Class
     12.4. Country 
             12.4.1. United States
             12.4.2. Canada

13 Europe Respiratory Disorders Treatment Market Size & Forecast 2022A-2032F 
     13.1. Overview 
     13.2. Key Findings 
     13.3. Market Segmentation 
             13.3.1. By Disease
             13.3.2. By Route of Administration
             13.3.3. By Drug Class
     13.4. Country 
             13.4.1. Germany
             13.4.2. United Kingdom
             13.4.3. France
             13.4.4. Italy
             13.4.5. Spain
             13.4.6. Russia
             13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14 Asia Respiratory Disorders Treatment Market Size & Forecast 2022A-2032F 
     14.1. Overview 
     14.2. Key Findings 
     14.3. Market Segmentation 
             14.3.1. By Disease
             14.3.2. By Route of Administration
             14.3.3. By Drug Class
     14.4. By Country 
             14.4.1. India
             14.4.2. China
             14.4.3. South Korea
             14.4.4. Japan
             14.4.5. Rest of APAC

15 Middle East and Africa Respiratory Disorders Treatment Market Size & Forecast 2022A-2032F 
     15.1. Overview 
     15.2. Key Findings 
     15.3. Market Segmentation 
             15.3.1. By Disease
             15.3.2. By Route of Administration
             15.3.3. By Drug Class 
     15.4. Country 
             15.4.1. Israel
             15.4.2. GCC
             15.4.3. North Africa
             15.4.4. South Africa
             15.4.5. Rest of Middle East and Africa

16 Latin America Respiratory Disorders Treatment Market Size & Forecast 2022A-2032F 
     16.1. Overview 
     16.2. Key Findings 
     16.3. Market Segmentation 
             16.3.1. By Disease
             16.3.2. By Route of Administration
             16.3.3. By Drug Class 
     16.4. Country 
             16.4.1. Mexico
             16.4.2. Brazil
             16.4.3. Rest of Latin America

17 Competitive Landscape 
     17.1. Company market share, 2021 
     17.2. Key player overview 
     17.3. Key stakeholders 

18 Company Profiles 
     18.1. Johnson & Johnson 
             18.1.1. Company Overview
             18.1.2. Financial Overview
             18.1.3. Key Product; Analysis
             18.1.4. Company Assessment
                        18.1.4.1 Product Portfolio
                        18.1.4.2 Key Clients
                        18.1.4.3 Market Share
                        18.1.4.4 Recent News & Development (Last 3 Yrs.)
                        18.1.4.5 Executive Team
     18.2. Novartis AG 
     18.3. F. Hoffmann-La Roche Ltd. 
     18.4. Sanofi 
     18.5. GlaxoSmithKline plc 
     18.6. Pfizer Inc. 
     18.7. AstraZeneca plc 
     18.8. Merck & Co. Inc. 
     18.9. Boehringer Ingelheim International GmbH 
     18.10. Teva Pharmaceutical Industries 
     18.11. Viatris 
     18.12. Cipla 
     18.13. CHIESI Farmaceutici S.p.A. 
     18.14. Sunovion Pharmaceuticals Inc. 
     18.15. Avalyn Pharma 
     18.16. Other Prominent Players 

19 Appendix 

20 Consultant Recommendation 
                                      

Research Methodology

Primary Research

  • Fatpos Global’s dedicated primary research wing comprises a team of analysts adept at conducting and engaging in detailed primary interviews with key industry stakeholders across the entire value chain.
  • The primary research comprises formulation of a detailed discussion guides composed of questions pertaining to various data points essential developing an in-depth report.
  • The subsequent stages development of an exhaustive market participants, key opinion leaders, industry experts and executives, among others.
  • Manufacturers, distributors & suppliers, key End Users, industry experts, opinion leaders, and industry association members, among others compose the sample for the research study

Supply Side

  • R&D technicians and technologists
  • Procurement Managers
  • Physician If s/Specialist
  • Research Professors
  • Healthcare Providers
  • Consumers
  • Distributors & Channels
  • Service Provide

Demand Side

  • CEOs
  • Vice presidents
  • Marketing directors
  • RProduct Managers
  • Regional Sales and
  • Marketing Managers
  • Business Development
  • Plant Manage

Research Framework

    Objective of Research

  • The objective of the research is to provide a 360 holistic view on the market and bringing the insights that can help stakeholders identify the opportunities as well as challenges.
  • We have provided the market size in terms of value and volume of market with segmentation and offers in-depth commentary and accurate quantitative insights.
  • The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

    Primary Research

  • Fatpos Global’s dedicated primary research wing comprises a team of analyst adept at conducting and engaging in detailed primary interviews with key industry stakeholders across the entire value chain.
  • The primary research comprises formulation of a detailed discussion guides composed of questions pertaining to various data points essential developing an in-depth report.
  • The subsequent stages development of an exhaustive market participants, key opinion leaders, industry experts and executives, among others.
  • Manufacturers, distributors & suppliers, key End Users, industry experts, opinion leaders, and industry association members, among others compose the sample for the research study
  • Analysts compile the whole data from demand and supply-side perceptions

    Secondary Research

  • Data is gathered from various secondary databases.
  • Diligently tracking the secondary sources for closely monitoring the market trends and insights.
  • Analysts compile the whole data from demand and supply-side perceptions for the better outputs.

Data Sources

    Research Approach

  • Demand Estimation of each product across countries/regions summed from the total market
  • Variable analysis for demand forecasting
  • Demand estimation via analysing paid database, company financials either via annual report or database
  • Primary interviews for data revalidation and insights collection.
  • Used extensively for new product forecasting or analysing penetration level
  • Tool used invoices product flow & penetration models
  • Use of regression multi variate analysis for forecasting
  • Involve extensive use of paid and public database
  • Primary interviews & vendor-based primary research for variable impact analysis

Bottom-Up Approach

Top-Down Approach

To request a free sample copy of this report, please complete the form below.

Purchase Report

Select your license

$3199

Compare all license features

Note: In case you require a hard copy, there will be an additional charge of $500.

Sample request

Read all reports

Our Clients

We have been working with some Fortune 500+ clients